The AffloVest, a portable high frequency chest wall oscillation vest, has been approved for reimbursement by Medicare and private health insurance, according to manufacturer International Biophysics Corporation (IBC). The AffloVest offers innovative airway clearance therapy that improves cough productivity and ease-of-breathing for chronic lung conditions, such as severe COPD, chronic bronchitis, and cystic fibrosis, according to the company.
Weighing approximately 10 pounds, the AffloVest is one of the lightest and quietest devices of its kind on the market today. The device provides adjustable levels of treatment intensity and multiple treatment modes. Doctors and patients can tailor treatments by utilizing settings that provide chest wall oscillation treatment on both the front and back of the vest.
AffloVest is available in sizes XS to XL, and is manufactured to fit children and adults with chronic lung conditions. The vest requires a physician’s prescription.
